Afya [AFYA] vs Stride [LRN] Detailed Stock Comparison

Afya

Stride
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Afya wins in 10 metrics, Stride wins in 9 metrics, with 0 ties. Afya appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Afya | Stride | Better |
---|---|---|---|
P/E Ratio (TTM) | 11.22 | 26.62 | Afya |
Price-to-Book Ratio | 0.31 | 4.60 | Afya |
Debt-to-Equity Ratio | 69.55 | 57.95 | Stride |
PEG Ratio | 1.41 | 21.81 | Afya |
EV/EBITDA | 2.64 | 14.76 | Afya |
Profit Margin (TTM) | 19.58% | 11.97% | Afya |
Operating Margin (TTM) | 31.02% | 5.38% | Afya |
EBITDA Margin (TTM) | 31.02% | 5.38% | Afya |
Return on Equity | 16.45% | 21.69% | Stride |
Return on Assets (TTM) | 8.42% | 12.45% | Stride |
Free Cash Flow (TTM) | $192.95M | $372.81M | Stride |
Dividend Yield | 1.26% | N/A | N/A |
1-Year Return | -3.94% | 91.93% | Stride |
Price-to-Sales Ratio (TTM) | 0.40 | 2.87 | Afya |
Enterprise Value | $666.59M | $6.90B | Stride |
EV/Revenue Ratio | 1.01 | 2.87 | Afya |
Gross Profit Margin (TTM) | 62.72% | 36.55% | Afya |
Revenue per Share (TTM) | $39 | $56 | Stride |
Earnings per Share (Diluted) | $1.40 | $5.95 | Stride |
Beta (Stock Volatility) | 0.57 | 0.23 | Stride |
Afya vs Stride Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Afya | -0.70% | 3.72% | 6.12% | -13.29% | -3.41% | -0.19% |
Stride | -1.69% | -1.47% | 0.62% | 11.55% | 31.93% | 48.92% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Afya | -3.94% | 11.74% | -34.58% | -34.52% | -34.52% | -34.52% |
Stride | 91.93% | 294.81% | 481.99% | 1,088.00% | 476.69% | 521.02% |
News Based Sentiment: Afya vs Stride
Afya
News based Sentiment: MIXED
September brought a flurry of analyst activity for Afya, with upgrades from both JPMorgan and UBS, but also adjustments to price targets due to concerns about M&A and taxation. This, combined with continued institutional investment, creates a mixed but noteworthy investment story.
Stride
News based Sentiment: POSITIVE
Stride delivered exceptional financial results in September, exceeding expectations on both revenue and earnings per share. Strategic partnerships and investments in AI-driven tutoring further strengthen the company's position in the growing K-12 education market, making it a compelling investment opportunity despite a single analyst downgrade.
Performance & Financial Health Analysis: Afya vs Stride
Metric | AFYA | LRN |
---|---|---|
Market Information | ||
Market Cap | $1.42B | $6.91B |
Market Cap Category | Small cap | Mid cap |
10 Day Avg. Volume | 96,280 | 533,620 |
90 Day Avg. Volume | 99,290 | 706,763 |
Last Close | $15.60 | $158.36 |
52 Week Range | $13.47 - $19.90 | $63.25 - $171.17 |
% from 52W High | -21.61% | -7.48% |
All-Time High | $34.87 (Dec 02, 2019) | $171.17 (Aug 27, 2025) |
% from All-Time High | -55.26% | -7.48% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.14% | 0.48% |
Quarterly Earnings Growth | 0.09% | 1.15% |
Financial Health | ||
Profit Margin (TTM) | 0.20% | 0.12% |
Operating Margin (TTM) | 0.31% | 0.05% |
Return on Equity (TTM) | 0.16% | 0.22% |
Debt to Equity (MRQ) | 69.55 | 57.95 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $50.62 | $34.46 |
Cash per Share (MRQ) | $12.10 | $8.97 |
Operating Cash Flow (TTM) | $285.17M | $432.82M |
Levered Free Cash Flow (TTM) | $54.71M | $297.65M |
Dividends | ||
Last 12-Month Dividend Yield | 1.26% | N/A |
Last 12-Month Dividend | $0.23 | $0.00 |
Valuation & Enterprise Metrics Analysis: Afya vs Stride
Metric | AFYA | LRN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 11.22 | 26.62 |
Forward P/E | 9.30 | 21.81 |
PEG Ratio | 1.41 | 21.81 |
Price to Sales (TTM) | 0.40 | 2.87 |
Price to Book (MRQ) | 0.31 | 4.60 |
Market Capitalization | ||
Market Capitalization | $1.42B | $6.91B |
Enterprise Value | $666.59M | $6.90B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.01 | 2.87 |
Enterprise to EBITDA | 2.64 | 14.76 |
Risk & Other Metrics | ||
Beta | 0.57 | 0.23 |
Book Value per Share (MRQ) | $50.62 | $34.46 |
Financial Statements Comparison: Afya vs Stride
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AFYA | LRN |
---|---|---|
Revenue/Sales | $170.57M | $653.65M |
Cost of Goods Sold | $63.58M | $414.73M |
Gross Profit | $106.99M | $238.92M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $52.92M | $116.34M |
EBITDA | $78.76M | $97.22M |
Pre-Tax Income | $35.99M | $64.33M |
Income Tax | $3.24M | $12.92M |
Net Income (Profit) | $32.75M | $51.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AFYA | LRN |
---|---|---|
Cash & Equivalents | $203.91M | $782.50M |
Total Current Assets | $349.34M | $1.63B |
Total Current Liabilities | $373.13M | $302.88M |
Long-Term Debt | $363.46M | $496.05M |
Total Shareholders Equity | $860.24M | $1.48B |
Retained Earnings | $427.90M | $846.45M |
Property, Plant & Equipment | $165.81M | $0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AFYA | LRN |
---|---|---|
Operating Cash Flow | $57.00M | $198.72M |
Capital Expenditures | $-8.00M | $-431,000 |
Free Cash Flow | $33.19M | $283.72M |
Debt Repayment | $5.92M | $-11.51M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AFYA | LRN |
---|---|---|
Shares Short | 274,682 | 3.73M |
Short Ratio | 2.73 | 4.92 |
Short % of Float | 0.01% | 0.12% |
Average Daily Volume (10 Day) | 96,280 | 533,620 |
Average Daily Volume (90 Day) | 99,290 | 706,763 |
Shares Outstanding | 16.75M | 43.52M |
Float Shares | 8.01M | 41.64M |
% Held by Insiders | 0.68% | 0.03% |
% Held by Institutions | 0.19% | 1.11% |
Dividend Analysis & Yield Comparison: Afya vs Stride
Metric | AFYA | LRN |
---|---|---|
Last 12-Month Dividend | $0.23 | $0.00 |
Last 12-Month Dividend Yield | 1.26% | N/A |
3-Year Avg Annual Dividend | $0.08 | $0.00 |
3-Year Avg Dividend Yield | 1.30% | N/A |
3-Year Total Dividends | $0.23 | $0.00 |
Ex-Dividend Date | Mar 26, 2025 | N/A |